FIELD: medicine, hysteroscopy. SUBSTANCE: the innovation is represented by LH-RH-antagonist, Cetrorelix, in particular. It is indicated to be used before hysteroscopy and/or preparation for operation, or in case of single usage ranged 0.1-2 mg/kg, or for preparation to operation at multiple dosage ranged 0.01-0.5 mg/kg, preferably distributed for 1-14 d. The suggested product could be used at hysteroscopy at combination with subsequent treatment of painful uterine states, for example, myoma and endometrial hyperplasia. The method enables to improve results of hysteroscopy and shorten the time necessary for preparation to operation. EFFECT: higher efficiency of diagnostics. 4 cl, 3 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR THERAPEUTIC TREATMENT OF EXTRAUTERINE PROLIFERATION OF ENDOMETRIAL TISSUE CHRONIC PAIN IN PELVIS REGION CAUSED BY THEREOF AND FALLOPIAN TUBES IMPENETRABILITY | 2000 |
|
RU2255759C2 |
| IMMOBILIZED AND STABILIZED COMPLEX OF LUTEINIZING HORMONE-RELEASING HORMONE ANTAGONIST, METHOD FOR ITS PREPARING, PROPOSED AGENT | 1998 |
|
RU2207151C2 |
| LHRH ANTAGONISTS, THEIR PREPARING, PHARMACEUTICAL COMPOSITION AND ITS PREPARING, METHOD FOR TREATMENT OF TUMOR AND INFERTILITY IN MAMMALS | 2001 |
|
RU2248982C9 |
| METHOD FOR THERAPEUTIC TREATMENT OF STERILITY | 1999 |
|
RU2221588C2 |
| METHOD FOR TREATING STERILITY | 2000 |
|
RU2226395C2 |
| METHOD FOR TREATMENT OF HYPERPLASTIC PROCESSES OF ENDOMETRIUM | 2007 |
|
RU2347567C1 |
| METHOD FOR DIAGNOSTICS OF ENDOMETRIUM PATHOLOGY IN PATIENTS WITH HYSTEROMYOMA | 2007 |
|
RU2334987C1 |
| METHOD OF HYPERPLASTIC ENDOMETRIUM PROCESSES DIAGNOSTICS AT HYSTEROMYOMA | 2007 |
|
RU2327164C1 |
| METHOD FOR APPLYING INTRAOPERATION CONTRAST ULTRASONIC DIAGNOSTIC EXAMINATION OF UTERINE DISEASES | 2001 |
|
RU2188580C1 |
| METHOD AND REMEDY FOR TREATING BENIGN HYPERPLASIA PROCESSES IN ENDOMETRIUM | 2004 |
|
RU2275194C1 |
